0.00Open0.00Pre Close0 Volume0 Open Interest10.50Strike Price0.00Turnover0.00%IV-40.54%PremiumOct 4, 2024Expiry Date7.16Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Hims & Hers Health Stock Discussion
nailed it
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
$Cloudflare (NET.US)$ $Hims & Hers Health (HIMS.US)$ $DocuSign (DOCU.US)$ $Invesco QQQ Trust (QQQ.US)$
No comment yet